Goldman Sachs’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-15,008
| Closed | -$36K | – | 4377 |
|
|
2018
Q2 | $36K | Sell |
15,008
-693
| -4% | -$1.66K | ﹤0.01% | 4090 |
|
|
2018
Q1 | $38K | Buy |
15,701
+804
| +5% | +$1.95K | ﹤0.01% | 4107 |
|
|
2017
Q4 | $36K | Sell |
14,897
-764
| -5% | -$1.85K | ﹤0.01% | 4059 |
|
|
2017
Q3 | $49K | Buy |
+15,661
| New | +$49K | ﹤0.01% | 4119 |
|
|
2017
Q2 | – | Sell |
-25,411
| Closed | -$94K | – | 4663 |
|
|
2017
Q1 | $94K | Sell |
25,411
-1,702
| -6% | -$6.3K | ﹤0.01% | 4133 |
|
|
2016
Q4 | $53K | Sell |
27,113
-5,444
| -17% | -$10.6K | ﹤0.01% | 4225 |
|
|
2016
Q3 | $203K | Buy |
32,557
+8,821
| +37% | +$55K | ﹤0.01% | 3931 |
|
|
2016
Q2 | $106K | Buy |
23,736
+10,896
| +85% | +$48.7K | ﹤0.01% | 4107 |
|
|
2016
Q1 | $135K | Buy |
12,840
+1,279
| +11% | +$13.4K | ﹤0.01% | 3933 |
|
|
2015
Q4 | $341K | Buy |
11,561
+7,929
| +218% | +$234K | ﹤0.01% | 3447 |
|
|
2015
Q3 | $115K | Sell |
3,632
-1,141
| -24% | -$36.1K | ﹤0.01% | 4117 |
|
|
2015
Q2 | $283K | Buy |
4,773
+2,252
| +89% | +$134K | ﹤0.01% | 3754 |
|
|
2015
Q1 | $269K | Sell |
2,521
-1,827
| -42% | -$195K | ﹤0.01% | 3714 |
|
|
2014
Q4 | $408K | Sell |
4,348
-12,108
| -74% | -$1.14M | ﹤0.01% | 3498 |
|
|
2014
Q3 | $1.26M | Sell |
16,456
-19,645
| -54% | -$1.51M | ﹤0.01% | 2767 |
|
|
2014
Q2 | $3.24M | Buy |
36,101
+30,557
| +551% | +$2.74M | ﹤0.01% | 2257 |
|
|
2014
Q1 | $297K | Buy |
5,544
+746
| +16% | +$40K | ﹤0.01% | 3693 |
|
|
2013
Q4 | $121K | Buy |
+4,798
| New | +$121K | ﹤0.01% | 4043 |
|